Composition:
Each tablet of Lapatinib 250 mg contains 250 mg of Lapatinib as the active ingredient.
Description:
HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medication Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients.
Lapatinib 250 mg is mainly prescribed for the treatment of:
Share your experience with our medical product. Write a review!
25 Mar 2026
Transdermal Patches 2026: Latest Trends, Benefits & How They’re Revolutionizing Pain & Nicotine Relief
Transdermal patches are advanced drug delivery systems that deliver medication through the skin directly into the bloodstream. In 2026, new health technology trends are making transdermal patches more
14 Mar 2026
How Carica Papaya Leaf Extract Supports Platelet Recovery: Evidence, Uses & Best Practices
A healthy platelet count is essential for proper clotting, immune defense, and overall blood health. When platelet levels fall below normal-commonly referred to as low platelet count-the body becomes
05 Feb 2026
Food Habits That Increase Diabetes Risk - And How Fenugreek Can Help Manage Blood Sugar Naturally
Diet plays a crucial role in the development and management of type 2 diabetes.
20 Jan 2026
PCOS Symptoms and Management: Signs Most Women Overlook
Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting millions of women worldwide. Early symptoms are often subtle and overlooked, which can delay diagnosis and treatment.
